Infiltrative Basal Cell Carcinoma (IBCC) is a type of skin cancer that, while less common than other skin cancers, can be quite challenging to manage. In this blog, we'll dive deep into what IBCC is, its treatment options, and how specialty pharmacies, like Senderra RX, play a crucial role in the management of this condition.
Infiltrative Basal Cell Carcinoma is a subtype of basal cell carcinoma, which is the most prevalent form of skin cancer. IBCC tends to grow more deeply into the skin's layers, making it a more aggressive and invasive form of the disease. It typically appears as a small, shiny bump on the skin, often with visible blood vessels or an open sore that won't heal. IBCC can occur on any part of the body but is most commonly found on sun-exposed areas like the face and neck.
Please consult with your physician for the best treatment course for you. The management of IBCC involves a range of treatment options, depending on the size, location, and extent of the tumor. These treatments may include:
Surgical excision is often the primary treatment for IBCC, where the cancerous tissue is cut out. The goal is to remove the tumor while preserving as much healthy tissue as possible.
This specialized surgical technique is particularly effective for IBCC, as it allows for precise removal of the tumor layer by layer, ensuring that no cancerous cells are left behind.
In cases where surgery is not suitable, or for patients with extensive disease, radiation therapy can be used to target and destroy cancer cells.
Some smaller IBCC lesions may be treated with topical medications, such as imiquimod or 5-fluorouracil, which stimulate the body's immune system to fight the cancer.
In some instances, specialty pharmacy medications are utilized to manage IBCC. These medications are often essential when other treatments are not effective or are contraindicated.
Specialty pharmacies like Senderra typically play a crucial role in the management of complex and chronic conditions, including certain types of cancers such as Infiltrative Basal Cell Carcinoma. In the context of Infiltrative BCC, specialty pharmacies contribute to the overall care and treatment in several ways:
Medication Dispensing: Specialty pharmacies often dispense specialized medications that may be prescribed for the treatment of Infiltrative BCC. This may include topical or systemic medications that are not typically available at regular retail pharmacies.
Patient Education: Specialty pharmacies often provide extensive education and support to patients. They help patients understand the prescribed medications, potential side effects, and the importance of adherence to the treatment plan. In the case of Infiltrative BCC, patients may need guidance on the proper application of topical medications or the management of side effects from systemic treatments.
Coordination of Care: These pharmacies may work closely with healthcare providers to ensure a coordinated and integrated approach to patient care. This includes communication with dermatologists, oncologists, and other healthcare professionals involved in the treatment of Infiltrative BCC.
Financial Assistance: Specialty pharmacies often assist patients in navigating the complexities of insurance coverage and may help in obtaining financial assistance programs or copay assistance for expensive medications used in the treatment of Infiltrative BCC.
Monitoring and Adherence Support: Continuous monitoring of patients' progress and adherence to treatment plans is crucial, especially in chronic conditions like cancer. Specialty pharmacies may employ systems to track medication adherence and provide support to patients to help them stay on course with their treatment.
Access to Limited Distribution Drugs: Some medications used in the treatment of Infiltrative BCC may have limited distribution, and specialty pharmacies are often equipped to manage the distribution and delivery of these drugs.
It's important to note that the specific role of a specialty pharmacy may vary, and the information provided here is a general overview. Patients and healthcare providers should work closely with specialty pharmacies to ensure that the unique needs of individuals with Infiltrative BCC are addressed effectively.
Additionally, advancements in cancer treatment may lead to changes in the role of specialty pharmacies over time.
Have more questions? Contact a Senderra representative today!
Senderra is a national specialty pharmacy, serving patients with challenging and ongoing medical conditions through provision of specialty medications, clinical expertise and support services.
We dedicate ourselves to designing and executing a model to serve the needs of our patients and partners (Prescribers, Pharma and Payers) in order to make a difference and effect positive outcomes.
Disclaimer:
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
Senderra: Dec 12, 2023 10:30:00 AM
Cancer.Net is the patient information website of the American Society of Clinical Oncology (ASCO). All patient education content is reviewed and...
Senderra: Dec 1, 2023 11:00:00 AM
An estimated 2.4 million people are living with Hepatitis C in the United States. About 4 in 10 people with Hepatitis C do not know they are...
Senderra: Nov 21, 2023 11:49:01 AM
Psoriatic Arthritis (PsA) is a chronic autoimmune disease that affects millions of people worldwide. It's a condition that not only causes joint pain...
Senderra